发明名称 |
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS |
摘要 |
Disclosed are synthetic nanocarrier methods, and related compositions, comprising administering MHC Class I-restricted and/or MHC Class II-restricted epitopes of an antigen and immunosuppressants in order to generate tolerogenic immune responses against the antigen, such as the generation of antigen-specific CD8+ regulatory T cells. |
申请公布号 |
US2016030555(A1) |
申请公布日期 |
2016.02.04 |
申请号 |
US201514810466 |
申请日期 |
2015.07.27 |
申请人 |
Selecta Biosciences, Inc. |
发明人 |
Kishimoto Takashi Kei;Fraser Christopher;Maldonado Roberto A. |
分类号 |
A61K39/385;A61K39/35 |
主分类号 |
A61K39/385 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method comprising:
(A) administering to a subject a composition that comprises: (i) a first population of synthetic nanocarriers coupled to immunosuppressants, and (ii) MHC Class I-restricted and/or MHC Class II-restricted epitopes of an antigen, wherein the composition is in an amount effective to generate antigen-specific CD8+ regulatory T cells in the subject; or (B) generating antigen-specific CD8+ regulatory T cells in a subject by administering a composition that comprises: (i) a first population of synthetic nanocarriers coupled to immunosuppressants, and (ii) MHC Class I-restricted and/or MHC Class II-restricted of an antigen; or (C) administering to a subject a composition according to a protocol that was previously shown to generate antigen-specific CD8+ regulatory T cells in one or more test subjects; wherein the composition comprises: (i) a first population of synthetic nanocarriers coupled to immunosuppressants, and (ii) MHC Class I-restricted and/or MHC Class II-restricted epitopes of an antigen. |
地址 |
Watertown MA US |